Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

The following table presents the special items charges (benefits) recorded by the Company, as well as the respective financial statement line items impacted:



		For the Years Ended December 31,
	2023	2022				2021
(In millions)		Pre-tax		After-tax		Pre-tax		After-tax		Pre-tax		After-tax
Loss (gain) on sale of businesses		$	1,499	$	1,429	$	(1,662)	$	(1,332)	$	—	$	—
Charge for organizational efficiency plan (Selling, general and administrative expenses)		252		193		22		17		168		119
Charges (benefits) associated with litigation matters (Selling, general and administrative expenses)		201		171		(28)		(20)		(27)		(21)
Integration and transaction-related costs (Selling, general and administrative expenses)		45		35		135		103		169		71
Deferred tax (benefits), net (Income taxes, less amount attributable to noncontrolling interests)		—		(1,071)		—		—		—		—
Debt extinguishment costs		—		—		—		—		141		110


Total impact from special items		$	1,997	$	757	$	(1,533)	$	(1,232)	$	451	$	279

Summarized Segment Financial Information

Effective January 1, 2023, we adopted amended accounting guidance for long-duration insurance contracts. See Note 2 to the Consolidated Financial Statements for further information. Prior period summarized segment information has been retrospectively adjusted to conform to this new basis of accounting. Summarized segment financial information was as follows:


(In millions)	Evernorth Health Services		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2023
Revenues from external customers	$	147,588	$	46,219	$	291	$	1	$	194,099
Intersegment revenues	5,670		4,332		—		(10,002)
Net investment income	241		597		305		23		1,166
Total revenues	153,499		51,148		596		(9,978)		195,265
Net realized investment results from certain equity method investments	—		57		—		—		57


Adjusted revenues	$	153,499	$	51,205	$	596	$	(9,978)	$	195,322
Depreciation and amortization	$	2,438	$	569	$	3	$	25	$	3,035
Income (loss) before income taxes	$	4,768	$	2,664	$	76	$	(1,995)	$	5,513
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests	(144)		(2)		—		—		(146)
Net realized investment losses (1)	—		133		2		—		135
Amortization of acquired intangible assets	1,774		45		—		—		1,819
Special items
Loss on sale of businesses	—		1,481		18		—		1,499
Charge for organizational efficiency plan	—		—		—		252		252
Charges associated with litigation matters	44		157		—		—		201
Integration and transaction-related costs	—		—		—		45		45




Pre-tax adjusted income (loss) from operations	$	6,442	$	4,478	$	96	$	(1,698)	$	9,318

(In millions)	Evernorth Health Services		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2022
Revenues from external customers	$	135,786	$	41,738	$	1,839	$	—	$	179,363
Intersegment revenues	4,463		2,535		—		(6,998)
Net investment income	86		638		424		7		1,155
Total revenues	140,335		44,911		2,263		(6,991)		180,518

Net realized investment results from certain equity method investments	—		126		—		—		126


Adjusted revenues	$	140,335	$	45,037	$	2,263	$	(6,991)	$	180,644
Depreciation and amortization	$	2,283	$	638	$	6	$	10	$	2,937
Income (loss) before income taxes	$	4,421	$	3,470	$	2,101	$	(1,595)	$	8,397
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests	(66)		(4)		(14)		—		(84)
Net realized investment losses (1)	—		530		83		—		613
Amortization of acquired intangible assets	1,772		103		1		—		1,876
Special items
(Gain) on sale of businesses	—		—		(1,662)		—		(1,662)
Charge for organizational efficiency plan	—		—		—		22		22
(Benefits) associated with litigation matters	—		—		—		(28)		(28)
Integration and transaction-related costs	—		—		—		135		135




Pre-tax adjusted income (loss) from operations	$	6,127	$	4,099	$	509	$	(1,466)	$	9,269

(1)Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.


(In millions)	Evernorth Health Services		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2021
Revenues from external customers	$	127,692	$	41,369	$	3,459	$	—	$	172,520
Intersegment revenues	4,203		2,271		—		(6,474)
Net investment income (loss)	17		1,003		530		(1)		1,549
Total revenues	131,912		44,643		3,989		(6,475)		174,069
Net realized investment results from certain equity method investments	—		—		—		—		—

Adjusted revenues	$	131,912	$	44,643	$	3,989	$	(6,475)	$	174,069
Depreciation and amortization	$	2,316	$	551	$	52	$	4	$	2,923
Income (loss) before income taxes	$	3,908	$	3,804	$	868	$	(1,790)	$	6,790
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests	(31)		(3)		(24)		—		(58)
Net realized investment losses (gains) (1)	4		(247)		45		—		(198)
Amortization of acquired intangible assets	1,937		47		14		—		1,998
Special items

Charge for organizational efficiency plan	—		—		—		168		168
(Benefits) associated with litigation matters	—		—		—		(27)		(27)
Integration and transaction-related costs	—		—		—		169		169

Debt extinguishment costs	—		—		—		141		141


Pre-tax adjusted income (loss) from operations	$	5,818	$	3,601	$	903	$	(1,339)	$	8,983

(1) Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.

Revenue from External Customers

Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. Prior period amounts have been retrospectively adjusted to reflect adoption of amended accounting guidance for long-duration insurance contracts (as discussed in Note 2 to the Consolidated Financial Statements) and to reflect the merger of the U.S. Commercial and U.S. Government operating segments into the U.S. Healthcare operating segment (as discussed in Note 1 to the Consolidated Financial Statements). The following table presents these revenues by product, premium and service type:


	For the Years Ended December 31,
(In millions)		2023		2022		2021
Products (Pharmacy revenues) (ASC 606)
Network revenues		$	67,514	$	64,946	$	64,992
Home delivery and specialty revenues		65,732		61,283		54,391
Other revenues		9,047		6,753		6,428
Intercompany eliminations		(5,050)		(4,416)		(4,398)
Total pharmacy revenues		137,243		128,566		121,413
Insurance premiums (ASC 944)
Cigna Healthcare
U.S. Healthcare
Employer insured		16,490		15,199		14,315
Medicare Advantage		8,771		7,896		8,362
Stop loss		6,143		5,461		4,868
Individual and Family Plans		5,088		2,636		2,528
Other		4,095		3,996		5,076
U.S. Healthcare		40,587		35,188		35,149
International Health		3,295		2,906		2,588
Total Cigna Healthcare		43,882		38,094		37,737
Divested International businesses		—		1,596		3,205
Other		281		225		221
Intercompany eliminations		74		1		(9)
Total premiums		44,237		39,916		41,154
Services (Fees) (ASC 606)
Evernorth Health Services		10,866		7,234		6,070
Cigna Healthcare		6,566		6,053		5,743
Other Operations		3		9		19
Other revenues		210		168		188
Intercompany eliminations		(5,026)		(2,583)		(2,067)
Total fees and other revenues		12,619		10,881		9,953
Total revenues from external customers		$	194,099	$	179,363	$	172,520

Foreign and U.S. Revenues from External Customers

U.S. and foreign revenues from external customers are shown below. The Company's foreign revenues are generated by its foreign operating entities. In the periods shown, no single foreign country contributed more than 2% of consolidated revenues from external customers.


	For the Years Ended December 31,
(In millions)	2023		2022		2021
United States	$	189,840	$	174,540	$	166,626
Foreign countries (1)	4,259		4,823		5,894
Total revenues from external customers	$	194,099	$	179,363	$	172,520

(1) The divested International businesses as described in Note 5 comprised of $1.6 billion and $3.2 billion in 2022 and 2021, respectively.